Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

China Steps Up Drug Plant Inspections

December 10, 2007 | A version of this story appeared in Volume 85, Issue 50

China's Vice Premier, Wu Yi, has announced that Chinese authorities will inspect chemical plants throughout the country to make sure that they are not producing pharmaceutical ingredients without authorization. She made the announcement while leading a delegation inspecting a toy factory and other plants in the southern province of Guangdong. Wu Yi said chemical plants producing pharmaceuticals without proper government clearance have been posing a public health risk. In the past year, the reputation of China's manufacturing sector has been tarnished by a series of scandals. Cough syrup made with counterfeit ingredients from China killed dozens of people in Panama a year ago. Last month, a toy made in China and sold in the U.S. was recalled after a researcher in an Australian hospital discovered it contained a toxic compound, 1,4-butanediol. Meanwhile, FDA is being pressured to improve its inspections of pharmaceutical plants in China that supply the U.S. market (C&EN, Nov. 26, page 38).

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.